Covid-19 Impact on Global Sofosbuvir (CAS 1190307-88-0) Market Insights, Forecast to 2026
The report is about Sofosbuvir API market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Sofosbuvir (CAS 1190307-88-0) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Sofosbuvir (CAS 1190307-88-0) industry.
Based on our recent survey, we have several different scenarios about the Sofosbuvir (CAS 1190307-88-0) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Sofosbuvir (CAS 1190307-88-0) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sofosbuvir (CAS 1190307-88-0) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sofosbuvir (CAS 1190307-88-0) market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Sofosbuvir (CAS 1190307-88-0) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Sofosbuvir (CAS 1190307-88-0) market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Sofosbuvir (CAS 1190307-88-0) market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Sofosbuvir (CAS 1190307-88-0) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sofosbuvir (CAS 1190307-88-0) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sofosbuvir (CAS 1190307-88-0) market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Sofosbuvir (CAS 1190307-88-0) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Sofosbuvir (CAS 1190307-88-0) industry.
Based on our recent survey, we have several different scenarios about the Sofosbuvir (CAS 1190307-88-0) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Sofosbuvir (CAS 1190307-88-0) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sofosbuvir (CAS 1190307-88-0) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sofosbuvir (CAS 1190307-88-0) market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Sofosbuvir (CAS 1190307-88-0) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Sofosbuvir (CAS 1190307-88-0) market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Sofosbuvir (CAS 1190307-88-0) market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Sofosbuvir (CAS 1190307-88-0) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sofosbuvir (CAS 1190307-88-0) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sofosbuvir (CAS 1190307-88-0) market.
The following manufacturers are covered in this report:
- Teva Pharmaceutical Industries Ltd
- DONG BANG FUTURE TECH & LIFE CO., LTD
- Beaukev Pharma International Pvt.Ltd
- DEAFARMA
- Tecoland
- Anhui HaiKang Pharmaceutical Co. Ltd
- Shanghai Haoyuan Chemexpress Co., Ltd
- Beijing Kawin Technology Share-holding Co
- Hangzhou Longshine Bio-Tech Co
- Purity ? 98%
- Purity ? 98%
- Adults Patients
- Elderly Patients
1 STUDY COVERAGE
1.1 Sofosbuvir (CAS 1190307-88-0) Product Introduction
1.2 Market Segments
1.3 Key Sofosbuvir (CAS 1190307-88-0) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Type
1.4.2 Purity ? 98%
1.4.3 Purity ? 98%
1.5 Market by Application
1.5.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Application
1.5.2 Adults Patients
1.5.3 Elderly Patients
1.6 Coronavirus Disease 2019 (Covid-19): Sofosbuvir (CAS 1190307-88-0) Industry Impact
1.6.1 How the Covid-19 is Affecting the Sofosbuvir (CAS 1190307-88-0) Industry
1.6.1.1 Sofosbuvir (CAS 1190307-88-0) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Sofosbuvir (CAS 1190307-88-0) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Sofosbuvir (CAS 1190307-88-0) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Estimates and Forecasts
2.1.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue 2015-2026
2.1.2 Global Sofosbuvir (CAS 1190307-88-0) Sales 2015-2026
2.2 Sofosbuvir (CAS 1190307-88-0) Market Size by Region: 2020 Versus 2026
2.2.1 Global Sofosbuvir (CAS 1190307-88-0) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sofosbuvir (CAS 1190307-88-0) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SOFOSBUVIR (CAS 1190307-88-0) COMPETITOR LANDSCAPE BY PLAYERS
3.1 Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturers
3.1.1 Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturers (2015-2020)
3.1.2 Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Manufacturers (2015-2020)
3.2 Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers
3.2.1 Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers (2015-2020)
3.2.2 Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sofosbuvir (CAS 1190307-88-0) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sofosbuvir (CAS 1190307-88-0) Revenue in 2019
3.2.5 Global Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sofosbuvir (CAS 1190307-88-0) Price by Manufacturers
3.4 Sofosbuvir (CAS 1190307-88-0) Manufacturing Base Distribution, Product Types
3.4.1 Sofosbuvir (CAS 1190307-88-0) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Type
3.4.3 Date of International Manufacturers Enter into Sofosbuvir (CAS 1190307-88-0) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020)
4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2015-2020)
4.1.3 Sofosbuvir (CAS 1190307-88-0) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Type (2021-2026)
4.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Type (2021-2026)
4.2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Type (2021-2026)
4.2.3 Sofosbuvir (CAS 1190307-88-0) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sofosbuvir (CAS 1190307-88-0) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
5.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020)
5.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2015-2020)
5.1.3 Sofosbuvir (CAS 1190307-88-0) Price by Application (2015-2020)
5.2 Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Application (2021-2026)
5.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Application (2021-2026)
5.2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Application (2021-2026)
5.2.3 Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Sofosbuvir (CAS 1190307-88-0) by Country
6.1.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Country
6.1.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
6.3 North America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
7 EUROPE
7.1 Europe Sofosbuvir (CAS 1190307-88-0) by Country
7.1.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country
7.1.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
7.3 Europe Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) by Region
8.1.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region
8.1.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
8.3 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Sofosbuvir (CAS 1190307-88-0) by Country
9.1.1 Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country
9.1.2 Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
9.3 Central & South America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) by Country
10.1.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country
10.1.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
10.3 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Teva Pharmaceutical Industries Ltd
11.1.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.1.2 Teva Pharmaceutical Industries Ltd Description, Business Overview and Total Revenue
11.1.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.1.5 Teva Pharmaceutical Industries Ltd Recent Development
11.2 DONG BANG FUTURE TECH & LIFE CO., LTD
11.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Corporation Information
11.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Description, Business Overview and Total Revenue
11.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sales, Revenue and Gross Margin (2015-2020)
11.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Products Offered
11.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development
11.3 Beaukev Pharma International Pvt.Ltd
11.3.1 Beaukev Pharma International Pvt.Ltd Corporation Information
11.3.2 Beaukev Pharma International Pvt.Ltd Description, Business Overview and Total Revenue
11.3.3 Beaukev Pharma International Pvt.Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.3.5 Beaukev Pharma International Pvt.Ltd Recent Development
11.4 DEAFARMA
11.4.1 DEAFARMA Corporation Information
11.4.2 DEAFARMA Description, Business Overview and Total Revenue
11.4.3 DEAFARMA Sales, Revenue and Gross Margin (2015-2020)
11.4.4 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Products Offered
11.4.5 DEAFARMA Recent Development
11.5 Tecoland
11.5.1 Tecoland Corporation Information
11.5.2 Tecoland Description, Business Overview and Total Revenue
11.5.3 Tecoland Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Tecoland Sofosbuvir (CAS 1190307-88-0) Products Offered
11.5.5 Tecoland Recent Development
11.6 Anhui HaiKang Pharmaceutical Co. Ltd
11.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Corporation Information
11.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Description, Business Overview and Total Revenue
11.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
11.7 Shanghai Haoyuan Chemexpress Co., Ltd
11.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Corporation Information
11.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Description, Business Overview and Total Revenue
11.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Recent Development
11.8 Beijing Kawin Technology Share-holding Co
11.8.1 Beijing Kawin Technology Share-holding Co Corporation Information
11.8.2 Beijing Kawin Technology Share-holding Co Description, Business Overview and Total Revenue
11.8.3 Beijing Kawin Technology Share-holding Co Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Products Offered
11.8.5 Beijing Kawin Technology Share-holding Co Recent Development
11.9 Hangzhou Longshine Bio-Tech Co
11.9.1 Hangzhou Longshine Bio-Tech Co Corporation Information
11.9.2 Hangzhou Longshine Bio-Tech Co Description, Business Overview and Total Revenue
11.9.3 Hangzhou Longshine Bio-Tech Co Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Products Offered
11.9.5 Hangzhou Longshine Bio-Tech Co Recent Development
11.1 Teva Pharmaceutical Industries Ltd
11.1.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.1.2 Teva Pharmaceutical Industries Ltd Description, Business Overview and Total Revenue
11.1.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.1.5 Teva Pharmaceutical Industries Ltd Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Sofosbuvir (CAS 1190307-88-0) Market Estimates and Projections by Region
12.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Regions 2021-2026
12.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Regions 2021-2026
12.2 North America Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.2.1 North America: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.2.2 North America: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.2.3 North America: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Country (2021-2026)
12.3 Europe Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.3.1 Europe: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.3.2 Europe: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.3.3 Europe: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Region (2021-2026)
12.5 Latin America Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.5.1 Latin America: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.5.2 Latin America: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.5.3 Latin America: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sofosbuvir (CAS 1190307-88-0) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Sofosbuvir (CAS 1190307-88-0) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Sofosbuvir (CAS 1190307-88-0) Product Introduction
1.2 Market Segments
1.3 Key Sofosbuvir (CAS 1190307-88-0) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Type
1.4.2 Purity ? 98%
1.4.3 Purity ? 98%
1.5 Market by Application
1.5.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Application
1.5.2 Adults Patients
1.5.3 Elderly Patients
1.6 Coronavirus Disease 2019 (Covid-19): Sofosbuvir (CAS 1190307-88-0) Industry Impact
1.6.1 How the Covid-19 is Affecting the Sofosbuvir (CAS 1190307-88-0) Industry
1.6.1.1 Sofosbuvir (CAS 1190307-88-0) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Sofosbuvir (CAS 1190307-88-0) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Sofosbuvir (CAS 1190307-88-0) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Estimates and Forecasts
2.1.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue 2015-2026
2.1.2 Global Sofosbuvir (CAS 1190307-88-0) Sales 2015-2026
2.2 Sofosbuvir (CAS 1190307-88-0) Market Size by Region: 2020 Versus 2026
2.2.1 Global Sofosbuvir (CAS 1190307-88-0) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sofosbuvir (CAS 1190307-88-0) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SOFOSBUVIR (CAS 1190307-88-0) COMPETITOR LANDSCAPE BY PLAYERS
3.1 Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturers
3.1.1 Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturers (2015-2020)
3.1.2 Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Manufacturers (2015-2020)
3.2 Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers
3.2.1 Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers (2015-2020)
3.2.2 Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sofosbuvir (CAS 1190307-88-0) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sofosbuvir (CAS 1190307-88-0) Revenue in 2019
3.2.5 Global Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sofosbuvir (CAS 1190307-88-0) Price by Manufacturers
3.4 Sofosbuvir (CAS 1190307-88-0) Manufacturing Base Distribution, Product Types
3.4.1 Sofosbuvir (CAS 1190307-88-0) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Type
3.4.3 Date of International Manufacturers Enter into Sofosbuvir (CAS 1190307-88-0) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Type (2015-2020)
4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020)
4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2015-2020)
4.1.3 Sofosbuvir (CAS 1190307-88-0) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Type (2021-2026)
4.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Type (2021-2026)
4.2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Type (2021-2026)
4.2.3 Sofosbuvir (CAS 1190307-88-0) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sofosbuvir (CAS 1190307-88-0) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Application (2015-2020)
5.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020)
5.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2015-2020)
5.1.3 Sofosbuvir (CAS 1190307-88-0) Price by Application (2015-2020)
5.2 Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Application (2021-2026)
5.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Application (2021-2026)
5.2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Application (2021-2026)
5.2.3 Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Sofosbuvir (CAS 1190307-88-0) by Country
6.1.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Country
6.1.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
6.3 North America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
7 EUROPE
7.1 Europe Sofosbuvir (CAS 1190307-88-0) by Country
7.1.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country
7.1.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
7.3 Europe Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) by Region
8.1.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region
8.1.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
8.3 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Sofosbuvir (CAS 1190307-88-0) by Country
9.1.1 Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country
9.1.2 Latin America Sofosbuvir (CAS 1190307-88-0) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
9.3 Central & South America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) by Country
10.1.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country
10.1.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Type
10.3 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Teva Pharmaceutical Industries Ltd
11.1.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.1.2 Teva Pharmaceutical Industries Ltd Description, Business Overview and Total Revenue
11.1.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.1.5 Teva Pharmaceutical Industries Ltd Recent Development
11.2 DONG BANG FUTURE TECH & LIFE CO., LTD
11.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Corporation Information
11.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Description, Business Overview and Total Revenue
11.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sales, Revenue and Gross Margin (2015-2020)
11.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Products Offered
11.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development
11.3 Beaukev Pharma International Pvt.Ltd
11.3.1 Beaukev Pharma International Pvt.Ltd Corporation Information
11.3.2 Beaukev Pharma International Pvt.Ltd Description, Business Overview and Total Revenue
11.3.3 Beaukev Pharma International Pvt.Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.3.5 Beaukev Pharma International Pvt.Ltd Recent Development
11.4 DEAFARMA
11.4.1 DEAFARMA Corporation Information
11.4.2 DEAFARMA Description, Business Overview and Total Revenue
11.4.3 DEAFARMA Sales, Revenue and Gross Margin (2015-2020)
11.4.4 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Products Offered
11.4.5 DEAFARMA Recent Development
11.5 Tecoland
11.5.1 Tecoland Corporation Information
11.5.2 Tecoland Description, Business Overview and Total Revenue
11.5.3 Tecoland Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Tecoland Sofosbuvir (CAS 1190307-88-0) Products Offered
11.5.5 Tecoland Recent Development
11.6 Anhui HaiKang Pharmaceutical Co. Ltd
11.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Corporation Information
11.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Description, Business Overview and Total Revenue
11.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
11.7 Shanghai Haoyuan Chemexpress Co., Ltd
11.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Corporation Information
11.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Description, Business Overview and Total Revenue
11.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Recent Development
11.8 Beijing Kawin Technology Share-holding Co
11.8.1 Beijing Kawin Technology Share-holding Co Corporation Information
11.8.2 Beijing Kawin Technology Share-holding Co Description, Business Overview and Total Revenue
11.8.3 Beijing Kawin Technology Share-holding Co Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Products Offered
11.8.5 Beijing Kawin Technology Share-holding Co Recent Development
11.9 Hangzhou Longshine Bio-Tech Co
11.9.1 Hangzhou Longshine Bio-Tech Co Corporation Information
11.9.2 Hangzhou Longshine Bio-Tech Co Description, Business Overview and Total Revenue
11.9.3 Hangzhou Longshine Bio-Tech Co Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Products Offered
11.9.5 Hangzhou Longshine Bio-Tech Co Recent Development
11.1 Teva Pharmaceutical Industries Ltd
11.1.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.1.2 Teva Pharmaceutical Industries Ltd Description, Business Overview and Total Revenue
11.1.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
11.1.5 Teva Pharmaceutical Industries Ltd Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Sofosbuvir (CAS 1190307-88-0) Market Estimates and Projections by Region
12.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Regions 2021-2026
12.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Regions 2021-2026
12.2 North America Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.2.1 North America: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.2.2 North America: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.2.3 North America: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Country (2021-2026)
12.3 Europe Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.3.1 Europe: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.3.2 Europe: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.3.3 Europe: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Region (2021-2026)
12.5 Latin America Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.5.1 Latin America: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.5.2 Latin America: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.5.3 Latin America: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sofosbuvir (CAS 1190307-88-0) Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Sofosbuvir (CAS 1190307-88-0) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Sofosbuvir (CAS 1190307-88-0) Market Segments
Table 2. Ranking of Global Top Sofosbuvir (CAS 1190307-88-0) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Purity ? 98%
Table 5. Major Manufacturers of Purity ? 98%
Table 6. COVID-19 Impact Global Market: (Four Sofosbuvir (CAS 1190307-88-0) Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Sofosbuvir (CAS 1190307-88-0) Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Sofosbuvir (CAS 1190307-88-0) Players to Combat Covid-19 Impact
Table 11. Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Sofosbuvir (CAS 1190307-88-0) Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Sofosbuvir (CAS 1190307-88-0) Sales by Regions 2015-2020 (MT)
Table 14. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Regions (2015-2020)
Table 15. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Manufacturers (2015-2020)
Table 18. Global Sofosbuvir (CAS 1190307-88-0) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Sofosbuvir (CAS 1190307-88-0) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sofosbuvir (CAS 1190307-88-0) as of 2019)
Table 20. Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Price (2015-2020) (USD/MT)
Table 23. Sofosbuvir (CAS 1190307-88-0) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Type
Table 25. Date of International Manufacturers Enter into Sofosbuvir (CAS 1190307-88-0) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 28. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2015-2020)
Table 29. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Type (2015-2020)
Table 31. Sofosbuvir (CAS 1190307-88-0) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 33. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2015-2020)
Table 34. North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 35. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 36. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 38. North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 39. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 40. North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 41. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 42. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 43. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 44. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 46. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 47. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 48. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 49. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 58. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 59. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 62. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 63. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 64. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 65. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 74. Teva Pharmaceutical Industries Ltd Corporation Information
Table 75. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 76. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Teva Pharmaceutical Industries Ltd Product
Table 78. Teva Pharmaceutical Industries Ltd Recent Development
Table 79. DONG BANG FUTURE TECH & LIFE CO., LTD Corporation Information
Table 80. DONG BANG FUTURE TECH & LIFE CO., LTD Description and Major Businesses
Table 81. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. DONG BANG FUTURE TECH & LIFE CO., LTD Product
Table 83. DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development
Table 84. Beaukev Pharma International Pvt.Ltd Corporation Information
Table 85. Beaukev Pharma International Pvt.Ltd Description and Major Businesses
Table 86. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Beaukev Pharma International Pvt.Ltd Product
Table 88. Beaukev Pharma International Pvt.Ltd Recent Development
Table 89. DEAFARMA Corporation Information
Table 90. DEAFARMA Description and Major Businesses
Table 91. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. DEAFARMA Product
Table 93. DEAFARMA Recent Development
Table 94. Tecoland Corporation Information
Table 95. Tecoland Description and Major Businesses
Table 96. Tecoland Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Tecoland Product
Table 98. Tecoland Recent Development
Table 99. Anhui HaiKang Pharmaceutical Co. Ltd Corporation Information
Table 100. Anhui HaiKang Pharmaceutical Co. Ltd Description and Major Businesses
Table 101. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Anhui HaiKang Pharmaceutical Co. Ltd Product
Table 103. Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
Table 104. Shanghai Haoyuan Chemexpress Co., Ltd Corporation Information
Table 105. Shanghai Haoyuan Chemexpress Co., Ltd Description and Major Businesses
Table 106. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Shanghai Haoyuan Chemexpress Co., Ltd Product
Table 108. Shanghai Haoyuan Chemexpress Co., Ltd Recent Development
Table 109. Beijing Kawin Technology Share-holding Co Corporation Information
Table 110. Beijing Kawin Technology Share-holding Co Description and Major Businesses
Table 111. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Beijing Kawin Technology Share-holding Co Product
Table 113. Beijing Kawin Technology Share-holding Co Recent Development
Table 114. Hangzhou Longshine Bio-Tech Co Corporation Information
Table 115. Hangzhou Longshine Bio-Tech Co Description and Major Businesses
Table 116. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Hangzhou Longshine Bio-Tech Co Product
Table 118. Hangzhou Longshine Bio-Tech Co Recent Development
Table 119. Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Regions (2021-2026) (MT)
Table 120. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2021-2026) (MT)
Table 124. North America: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2021-2026) (MT)
Table 126. Europe: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Region (2021-2026) (MT)
Table 128. Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2021-2026) (MT)
Table 130. Latin America: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2021-2026) (MT)
Table 132. Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Sofosbuvir (CAS 1190307-88-0) Players
Table 137. Sofosbuvir (CAS 1190307-88-0) Customers List
Table 138. Sofosbuvir (CAS 1190307-88-0) Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 1. Sofosbuvir (CAS 1190307-88-0) Market Segments
Table 2. Ranking of Global Top Sofosbuvir (CAS 1190307-88-0) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Purity ? 98%
Table 5. Major Manufacturers of Purity ? 98%
Table 6. COVID-19 Impact Global Market: (Four Sofosbuvir (CAS 1190307-88-0) Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Sofosbuvir (CAS 1190307-88-0) Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Sofosbuvir (CAS 1190307-88-0) Players to Combat Covid-19 Impact
Table 11. Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Sofosbuvir (CAS 1190307-88-0) Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Sofosbuvir (CAS 1190307-88-0) Sales by Regions 2015-2020 (MT)
Table 14. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Regions (2015-2020)
Table 15. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Manufacturers (2015-2020)
Table 18. Global Sofosbuvir (CAS 1190307-88-0) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Sofosbuvir (CAS 1190307-88-0) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sofosbuvir (CAS 1190307-88-0) as of 2019)
Table 20. Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Sofosbuvir (CAS 1190307-88-0) Price (2015-2020) (USD/MT)
Table 23. Sofosbuvir (CAS 1190307-88-0) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Sofosbuvir (CAS 1190307-88-0) Product Type
Table 25. Date of International Manufacturers Enter into Sofosbuvir (CAS 1190307-88-0) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 28. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2015-2020)
Table 29. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Type (2015-2020)
Table 31. Sofosbuvir (CAS 1190307-88-0) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 33. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2015-2020)
Table 34. North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 35. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 36. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 38. North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 39. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 40. North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 41. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 42. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 43. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 44. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 46. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 47. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 48. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 49. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 58. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 59. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 62. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 63. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 64. Latin America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 65. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Table 74. Teva Pharmaceutical Industries Ltd Corporation Information
Table 75. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 76. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Teva Pharmaceutical Industries Ltd Product
Table 78. Teva Pharmaceutical Industries Ltd Recent Development
Table 79. DONG BANG FUTURE TECH & LIFE CO., LTD Corporation Information
Table 80. DONG BANG FUTURE TECH & LIFE CO., LTD Description and Major Businesses
Table 81. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. DONG BANG FUTURE TECH & LIFE CO., LTD Product
Table 83. DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development
Table 84. Beaukev Pharma International Pvt.Ltd Corporation Information
Table 85. Beaukev Pharma International Pvt.Ltd Description and Major Businesses
Table 86. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Beaukev Pharma International Pvt.Ltd Product
Table 88. Beaukev Pharma International Pvt.Ltd Recent Development
Table 89. DEAFARMA Corporation Information
Table 90. DEAFARMA Description and Major Businesses
Table 91. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. DEAFARMA Product
Table 93. DEAFARMA Recent Development
Table 94. Tecoland Corporation Information
Table 95. Tecoland Description and Major Businesses
Table 96. Tecoland Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Tecoland Product
Table 98. Tecoland Recent Development
Table 99. Anhui HaiKang Pharmaceutical Co. Ltd Corporation Information
Table 100. Anhui HaiKang Pharmaceutical Co. Ltd Description and Major Businesses
Table 101. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Anhui HaiKang Pharmaceutical Co. Ltd Product
Table 103. Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
Table 104. Shanghai Haoyuan Chemexpress Co., Ltd Corporation Information
Table 105. Shanghai Haoyuan Chemexpress Co., Ltd Description and Major Businesses
Table 106. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Shanghai Haoyuan Chemexpress Co., Ltd Product
Table 108. Shanghai Haoyuan Chemexpress Co., Ltd Recent Development
Table 109. Beijing Kawin Technology Share-holding Co Corporation Information
Table 110. Beijing Kawin Technology Share-holding Co Description and Major Businesses
Table 111. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Beijing Kawin Technology Share-holding Co Product
Table 113. Beijing Kawin Technology Share-holding Co Recent Development
Table 114. Hangzhou Longshine Bio-Tech Co Corporation Information
Table 115. Hangzhou Longshine Bio-Tech Co Description and Major Businesses
Table 116. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Hangzhou Longshine Bio-Tech Co Product
Table 118. Hangzhou Longshine Bio-Tech Co Recent Development
Table 119. Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Regions (2021-2026) (MT)
Table 120. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2021-2026) (MT)
Table 124. North America: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2021-2026) (MT)
Table 126. Europe: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Region (2021-2026) (MT)
Table 128. Asia Pacific: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2021-2026) (MT)
Table 130. Latin America: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Country (2021-2026) (MT)
Table 132. Middle East and Africa: Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Sofosbuvir (CAS 1190307-88-0) Players
Table 137. Sofosbuvir (CAS 1190307-88-0) Customers List
Table 138. Sofosbuvir (CAS 1190307-88-0) Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Sofosbuvir (CAS 1190307-88-0) Product Picture
Figure 2. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type in 2020 & 2026
Figure 3. Purity ? 98% Product Picture
Figure 4. Purity ? 98% Product Picture
Figure 5. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application in 2020 & 2026
Figure 6. Adults Patients
Figure 7. Elderly Patients
Figure 8. Sofosbuvir (CAS 1190307-88-0) Report Years Considered
Figure 9. Global Sofosbuvir (CAS 1190307-88-0) Market Size 2015-2026 (US$ Million)
Figure 10. Global Sofosbuvir (CAS 1190307-88-0) Sales 2015-2026 (MT)
Figure 11. Global Sofosbuvir (CAS 1190307-88-0) Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2015-2020)
Figure 13. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region in 2019
Figure 14. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2015-2020)
Figure 15. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region in 2019
Figure 16. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Sofosbuvir (CAS 1190307-88-0) Revenue in 2019
Figure 18. Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Figure 20. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type in 2019
Figure 21. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2015-2020)
Figure 22. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type in 2019
Figure 23. Global Sofosbuvir (CAS 1190307-88-0) Market Share by Price Range (2015-2020)
Figure 24. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Figure 25. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application in 2019
Figure 26. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2015-2020)
Figure 27. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application in 2019
Figure 28. North America Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 29. North America Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 31. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 32. U.S. Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 33. U.S. Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 35. Canada Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 37. North America Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 38. Europe Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 39. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 41. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 42. Germany Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 43. Germany Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 45. France Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 47. U.K. Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 49. Italy Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 51. Russia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 53. Europe Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 54. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 55. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region in 2019
Figure 57. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region in 2019
Figure 58. China Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 59. China Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 61. Japan Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 63. South Korea Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 65. India Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 67. Australia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 69. Taiwan Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 71. Indonesia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 73. Thailand Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 75. Malaysia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 77. Philippines Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 79. Vietnam Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 81. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 82. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 83. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 85. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 86. Mexico Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 87. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 89. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 91. Argentina Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 93. Latin America Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 94. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 95. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 98. Turkey Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 99. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 101. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 103. U.A.E Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 105. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 106. Teva Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. DONG BANG FUTURE TECH & LIFE CO., LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Beaukev Pharma International Pvt.Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. DEAFARMA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Tecoland Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Anhui HaiKang Pharmaceutical Co. Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Shanghai Haoyuan Chemexpress Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Beijing Kawin Technology Share-holding Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Hangzhou Longshine Bio-Tech Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 116. North America Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 118. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 120. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 122. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 124. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
Figure 1. Sofosbuvir (CAS 1190307-88-0) Product Picture
Figure 2. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type in 2020 & 2026
Figure 3. Purity ? 98% Product Picture
Figure 4. Purity ? 98% Product Picture
Figure 5. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application in 2020 & 2026
Figure 6. Adults Patients
Figure 7. Elderly Patients
Figure 8. Sofosbuvir (CAS 1190307-88-0) Report Years Considered
Figure 9. Global Sofosbuvir (CAS 1190307-88-0) Market Size 2015-2026 (US$ Million)
Figure 10. Global Sofosbuvir (CAS 1190307-88-0) Sales 2015-2026 (MT)
Figure 11. Global Sofosbuvir (CAS 1190307-88-0) Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2015-2020)
Figure 13. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region in 2019
Figure 14. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2015-2020)
Figure 15. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region in 2019
Figure 16. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Sofosbuvir (CAS 1190307-88-0) Revenue in 2019
Figure 18. Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2015-2020)
Figure 20. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type in 2019
Figure 21. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2015-2020)
Figure 22. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type in 2019
Figure 23. Global Sofosbuvir (CAS 1190307-88-0) Market Share by Price Range (2015-2020)
Figure 24. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
Figure 25. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application in 2019
Figure 26. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2015-2020)
Figure 27. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application in 2019
Figure 28. North America Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 29. North America Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 31. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 32. U.S. Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 33. U.S. Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 35. Canada Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 37. North America Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 38. Europe Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 39. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 41. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 42. Germany Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 43. Germany Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 45. France Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 47. U.K. Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 49. Italy Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 51. Russia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 53. Europe Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 54. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 55. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region in 2019
Figure 57. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region in 2019
Figure 58. China Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 59. China Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 61. Japan Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 63. South Korea Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 65. India Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 67. Australia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 69. Taiwan Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 71. Indonesia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 73. Thailand Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 75. Malaysia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 77. Philippines Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 79. Vietnam Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 81. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 82. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 83. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 85. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 86. Mexico Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 87. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 89. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 91. Argentina Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 93. Latin America Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 94. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate 2015-2020 (MT)
Figure 95. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country in 2019
Figure 98. Turkey Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 99. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 101. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate (2015-2020) (MT)
Figure 103. U.A.E Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Share by Type in 2019
Figure 105. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Share by Application in 2019
Figure 106. Teva Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. DONG BANG FUTURE TECH & LIFE CO., LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Beaukev Pharma International Pvt.Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. DEAFARMA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Tecoland Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Anhui HaiKang Pharmaceutical Co. Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Shanghai Haoyuan Chemexpress Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Beijing Kawin Technology Share-holding Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Hangzhou Longshine Bio-Tech Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 116. North America Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 118. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 120. Asia Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 122. Latin America Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 124. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed
